WEBINAR
Adoptive T-cell therapy – Solutions for T-cell engineering and expansion
Adoptive T-cell therapy is a promising development in cancer immunotherapy and the number of clinical trials is rapidly increasing every year. However, method optimization is still necessary to produce T cells at large scale. In this webinar, we will discuss tools for improving the T-cell engineering and expansion process to maximize the therapeutic potential of patient-derived T cells.
The webinar will cover the following topics:
- Efficient serum-free T-cell culture using LymphoONE™ Medium
- Benefits of RetroNectin® stimulation to ensure a high proportion of naïve-like T cells
- Footprint-free T-cell engineering
- T-cell engineering using viral delivery
SPEAKER
Cornelia Hampe, PhD
Senior Product Manager
Takara Bio Europe